New York
Provider Communications
Important update to Empire’s commercial drug lists
Effective with dates of service on and after October 1, 2019, and in accordance with Empire’s Pharmacy and Therapeutic (P&T) process, Empire BlueCross BlueShield (“Empire”) will update its commercial drug lists. Updates may include changes to drug tiers or the removal of a drug.
Featured In:
October 2019 Empire Provider News
To help ensure a smooth transition and minimize member costs, providers should review these changes and consider prescribing a preferred drug to patients currently using a non-preferred drug, if appropriate.
Please note, this update does not apply to the Select Drug List or drugs lists utilized by the Federal Employee Program (FEP).
To view a summary of changes, click on the attachment.
Featured In:
October 2019 Empire Provider News